2P-DOX

(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl 2,3,6-trideoxy-3-(2,3-dihydro-1H-pyrrol-1-yl)-α-L-lyxo-hexopyranoside

(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl-2,3,6-tridesoxy-3-(2,3-dihydro-1H-pyrrol-1-yl)-α-L-lyxo-hexopyranosid

175795-76-3

2,3,6-Tridésoxy-3-(2,3-dihydro-1H-pyrrol-1-yl)-α-L-lyxo-hexopyranoside de (1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacétyl)-10-méthoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tétracényle

2P-DOX

5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-(2,3-dihydro-1H-pyrrol-1-yl)-α-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)-

2-pyrrolino-DOX

2-pyrrolinodoxorubicin

5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-3-(2,3-dihydro-1H-pyrrol-1-yl)-α-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-